Recombinant Human Vimentin #abs01285

abs01285-20ug

1-2 Weeks

138

abs01285-100ug

1-2 Weeks

344

abs01285-1mg

1-2 Weeks

1425

Source

Escherichia coli.

Format

The solution was filtered through a 0.2 μm filter and lyophilized. The resulting product contained 30% acetonitrile and 0.1% TFA. A similar content can be generated by stating that the original solution was dehydrated in the presence of 30% acetonitrile and 0.1% TFA, after prior filtration using a 0.2 μm filter.

Properties

aa_sequence

YLPGALGSSR VTYRGPTSRF GSYSSRTVSR SLRPTYSSVT SPRSRVYTTS GVYSAPGSLR RLRLRASVVP GVQRLPSSVS FQDVSDLTAN TRKFELNQTkN RQLDINIYKV EQQKILLNLA EQGLLREKQE YDGLRSLKER VQREREDALV DAKNLEIDMR EKMRLQELRE NAEERQLQFS VDQRLSALDN LELEEISQVK EHEFEEIQKL EAIQEVQIHV DVSVIDLPDK LETARALDVP AEVQSYREKQ WYAEWEENLK FDSLAQAKRN DSEARQNQYE VVCLTESQDL LEGTNKSARE ENFMEEMRQR DNTVAQYENA KQDIQLGREN RLRAHMEEMK MVDLNLLEQI TYRKESGLAE IFFHSSRLNS LSDLPNLETN SLDLPLTLRN TGIRKVETDL SHIVERNEGV ENTRV.

Concentration

> 95 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The LAL method has determined that Recombinant Human Vimentin contains less than 0.1 EU/microgram. Similar content can be created by rephrasing the original information, taking care to maintain its accuracy.

Reconstitution

It is recommended to briefly centrifuge the vial before opening in order to settle the contents at the bottom. Reconstitute the vial in 4 mM HCl, achieving a concentration of 0.1-1.0 mg/mL. It is advisable to divide the stock solution into separate working aliquots and store them at temperatures of less than or equal to -20 °C. When making further dilutions, use appropriate buffered solutions.

Stability & Storage

To ensure the stability of this lyophilized preparation, it is recommended to keep it at a temperature range of 2-8 °C. However, for long term storage, it is best to store it at -20 °C while ensuring that it is desiccated. Once the preparation is reconstituted, it can remain stable for up to one week when stored at 2-8 °C. For optimal stability, it is advisable to distribute the reconstituted preparation into working aliquots and keep them at a temperature range of -20 °C to -70 °C. It is important to avoid repeated freeze/thaw cycles to prevent any adverse effects on the preparation's integrity.

Target

Accession

P08670

Gene IDs

7431